These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 12648610

  • 21. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB, Zhang L, Yang LY.
    Ren Fail; 2012 Aug; 34(1):83-7. PubMed ID: 22011322
    [Abstract] [Full Text] [Related]

  • 27. [Effect of bone morphogenic protein 7 on nephrin expression and distribution in diabetic rat kidneys].
    Xiao HQ, Shi W, Zhang Y, Liang YZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):671-5. PubMed ID: 19403392
    [Abstract] [Full Text] [Related]

  • 28. Effect of Lepidium sativum L. on renal glucose reabsorption and urinary TGF-beta 1 levels in diabetic rats.
    Eddouks M, Maghrani M.
    Phytother Res; 2008 Jan; 22(1):1-5. PubMed ID: 18064603
    [Abstract] [Full Text] [Related]

  • 29. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N, Yokozawa T.
    J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
    [Abstract] [Full Text] [Related]

  • 30. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
    Qi W, Chen X, Zhang Y, Holian J, Mreich E, Gilbert RE, Kelly DJ, Pollock CA.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
    [Abstract] [Full Text] [Related]

  • 31. Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.
    Chen LL, Zhang JY, Wang BP.
    Vascul Pharmacol; 2006 May; 44(5):309-15. PubMed ID: 16624630
    [Abstract] [Full Text] [Related]

  • 32. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW.
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [Abstract] [Full Text] [Related]

  • 33. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.
    Nakagawa T, Yokozawa T, Yamabe N, Rhyn DY, Goto H, Shimada Y, Shibahara N.
    J Pharm Pharmacol; 2005 Sep; 57(9):1205-12. PubMed ID: 16105242
    [Abstract] [Full Text] [Related]

  • 34. Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats.
    da Silva AS, Dias LD, Borges JF, Markoski MM, de Souza MS, Irigoyen MC, Machado UF, Schaan BD.
    Life Sci; 2013 Jul 10; 92(24-26):1174-9. PubMed ID: 23680377
    [Abstract] [Full Text] [Related]

  • 35. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 10; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 36. Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study.
    Flores L, Näf S, Hernáez R, Conget I, Gomis R, Esmatjes E.
    Diabet Med; 2004 Aug 10; 21(8):818-22. PubMed ID: 15270783
    [Abstract] [Full Text] [Related]

  • 37. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
    Fernandes R, Carvalho AL, Kumagai A, Seica R, Hosoya K, Terasaki T, Murta J, Pereira P, Faro C.
    Mol Vis; 2004 Aug 30; 10():618-28. PubMed ID: 15359219
    [Abstract] [Full Text] [Related]

  • 38. Increased epidermal growth factor in experimental diabetes related kidney growth in rats.
    Gilbert RE, Cox A, McNally PG, Wu LL, Dziadek M, Cooper ME, Jerums G.
    Diabetologia; 1997 Jul 30; 40(7):778-85. PubMed ID: 9243098
    [Abstract] [Full Text] [Related]

  • 39. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
    Lin Y, Sun Z.
    J Endocrinol; 2011 May 30; 209(2):185-91. PubMed ID: 21307121
    [Abstract] [Full Text] [Related]

  • 40. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G, Paczek L, Kropiewnicka E, Bartłomiejczyk I.
    Pol Merkur Lekarski; 2002 Nov 30; 13 Suppl 1():28-32. PubMed ID: 12621778
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.